Acquisition by Riedel Norbert G of 547 shares of Genetic Technologies at 1.57 subject to Rule 16b-3

Read at macroaxis.com

Published over six months ago View all stories for Invictus | Invictus Hype Analysis

Acquisition of 547 stock options (right to buy) at 1.57 of Genetic Technologies by Riedel Norbert G on 14th of August 2024. This event was filed by Genetic Technologies with SEC on 2004-04-13. Statement of changes in beneficial ownership - SEC Form 4

We analyze Invictus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invictus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invictus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Invictus stock to make a market-neutral strategy. Peer analysis of Invictus could also be used in its relative valuation, which is a method of valuing Invictus by comparing valuation metrics with similar companies.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

If you are still planning to invest in Invictus MD Strategies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invictus' history and understand the potential risks before investing.